Literature DB >> 12838550

Visual-spatial performance deficits in children with neurofibromatosis type-1.

Gregory W Schrimsher1, Rebecca L Billingsley, John M Slopis, Bartlett D Moore.   

Abstract

Neurofibromatosis type-1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in visual-spatial/motor abilities enable one to discriminate and classify children with NF1 (n = 101) compared to control children (n = 37), beyond effects secondary to parent reported ADHD symptomology. Discriminant analysis showed a multivariate combination of visual-spatial/motor ability tests (Judgment of Line Orientation, Block Design subtest of the WISC-III, Recognition-Discrimination Test, Beery Visual-Motor Integration Test) to be a significant predictor of NF1 diagnostic status (P = 0.0000004; canonical R(2) = 0.2306). A significantly greater degree of ADHD behavior was found in the NF1 group, and a discriminant analysis using ADHD residualized visual-spatial motor scores indicated that the combination of tests continued to be a significant predictor of group membership after the level of ADHD behavior was controlled (P = 0.00002 and a canonical R(2) = 0.1818). This combination of tests proved to be a strong discriminator of NF1. It correctly identified 90% of individuals with the diagnosis, and may be useful to educators to provide assistance and alternatives to minimize the impact of learning problems in those with either known or suspected NF1. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12838550     DOI: 10.1002/ajmg.a.20048

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

1.  Disruption of Critical Period Plasticity in a Mouse Model of Neurofibromatosis Type 1.

Authors:  Mariska van Lier; M Hadi Saiepour; Koen Kole; Juliette E Cheyne; Nawal Zabouri; Thomas Blok; Yi Qin; Emma Ruimschotel; J Alexander Heimel; Christian Lohmann; Christiaan N Levelt
Journal:  J Neurosci       Date:  2020-06-11       Impact factor: 6.167

2.  Clinical case rounds in child and adolescent psychiatry: neurofibromatosis type 1, cognitive impairment, and attention deficit hyperactivity disorder.

Authors:  Nicola Keyhan; Debbie Minden; Abel Ickowicz
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2006-05

3.  Cognitive profile of children with neurofibromatosis and reading disabilities.

Authors:  Laurie E Cutting; Terry M Levine
Journal:  Child Neuropsychol       Date:  2010       Impact factor: 2.500

4.  Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.

Authors:  Jacquelyn A Brown; Ryan J Emnett; Crystal R White; Carla M Yuede; Sara B Conyers; Karen L O'Malley; David F Wozniak; David H Gutmann
Journal:  Hum Mol Genet       Date:  2010-09-07       Impact factor: 6.150

5.  Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: correlation with T2 hyperintensities.

Authors:  Charlotte Barbier; Camille Chabernaud; Laurent Barantin; Philippe Bertrand; Catherine Sembely; Dominique Sirinelli; Pierre Castelnau; Jean-Philippe Cottier
Journal:  Neuroradiology       Date:  2010-10-20       Impact factor: 2.804

6.  Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables.

Authors:  Staci Martin; Pamela Wolters; Andrea Baldwin; Andrea Gillespie; Eva Dombi; Katherine Walker; Brigitte Widemann
Journal:  J Pediatr Psychol       Date:  2012-02-21

7.  Visuospatial processing in children with neurofibromatosis type 1.

Authors:  Amy M Clements-Stephens; Sheryl L Rimrodt; Pooja Gaur; Laurie E Cutting
Journal:  Neuropsychologia       Date:  2007-10-02       Impact factor: 3.139

8.  Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1.

Authors:  João V Duarte; Maria J Ribeiro; Inês R Violante; Gil Cunha; Eduardo Silva; Miguel Castelo-Branco
Journal:  Hum Brain Mapp       Date:  2012-09-11       Impact factor: 5.038

9.  Visuoperceptual Impairment in Children with NF1: From Early Visual Processing to Procedural Strategies.

Authors:  Sara Bulgheroni; Matilde Taddei; Veronica Saletti; Silvia Esposito; Roberto Micheli; Daria Riva
Journal:  Behav Neurol       Date:  2019-01-13       Impact factor: 3.342

10.  Sporadic and Familial Variants in NF1: An Explanation of the Wide Variability in Neurocognitive Phenotype?

Authors:  Maëlle Biotteau; Sébastien Déjean; Sandrine Lelong; Stéphanie Iannuzzi; Nathalie Faure-Marie; Pierre Castelnau; François Rivier; Valérie Lauwers-Cancès; Eloïse Baudou; Yves Chaix
Journal:  Front Neurol       Date:  2020-05-05       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.